These results suggested that quercetin may serve as a therapeutic adjuvant to 5-FU by targeting TS to inhibit tumorigenesis, although the in vivo regulatory function of candidate tiRNAs on tumor growth requires further study. Here, TYMS is linked to neoplasm.